• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,471.68 111.67
( 0.15%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
391.1437121
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
35.01
85006.13
EPS(TTM)
Face Value()
Div & Yield %
41.81
1
0
 

Shri Jagdamba Polymers consolidated net profit declines 45.61% in the March 2026 quarter
May 20,2026
Net profit of Shri Jagdamba Polymers declined 45.61% to Rs 8.74 crore in the quarter ended March 2026 as against Rs 16.07 crore during the previous quarter ended March 2025. Sales declined 9.60% to Rs 108.03 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025.

For the full year,net profit declined 22.50% to Rs 37.27 crore in the year ended March 2026 as against Rs 48.09 crore during the previous year ended March 2025. Sales declined 10.49% to Rs 430.97 crore in the year ended March 2026 as against Rs 481.48 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales108.03119.50 -10 430.97481.48 -10
OPM %8.3718.08 -10.2614.38 -
PBDT15.6825.08 -37 59.1973.30 -19
PBT12.7822.92 -44 47.7164.90 -26
NP8.7416.07 -46 37.2748.09 -22